Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Advertisement
U.S. markets open in 1 hour 20 minutes
S&P Futures
5,193.25
-21.50
(-0.41%)
Dow Futures
39,154.00
-69.00
(-0.18%)
Nasdaq Futures
18,119.25
-112.25
(-0.62%)
Russell 2000 Futures
2,040.60
-9.20
(-0.45%)
Crude Oil
82.68
-0.04
(-0.05%)
Gold
2,158.80
-5.50
(-0.25%)
Protalix BioTherapeutics, Inc. (PLX)
NYSE American - NYSE American Delayed Price. Currency in USD
Follow
Visitors trend
2W
10W
9M
1.2700
-0.0600
(-4.51%)
At close: 04:00PM EDT
1.2700
0.00
(0.00%)
Pre-Market:
08:04AM EDT
Summary
Company Insights
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Subscribe to Yahoo Finance Plus Essential to download historical data
Download
Income Statement
Expand All
All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Learn more
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
65,494
65,494
47,638
38,350
62,898
Cost of Revenue
22,982
22,982
19,592
16,349
10,873
Gross Profit
42,512
42,512
28,046
22,001
52,025
Operating Expense
32,052
32,052
41,060
42,463
49,315
Operating Income
10,460
10,460
-13,014
-20,462
2,710
Net Non Operating Interest Income Expense
-1,894
-1,894
-1,383
-7,120
-9,233
Pretax Income
8,566
8,566
-14,397
-27,582
-6,523
Tax Provision
254
254
530
0
-
Net Income Common Stockholders
8,312
8,312
-14,927
-27,582
-6,523
Diluted NI Available to Com Stockholders
8,312
8,312
-14,927
-27,582
-6,523
Basic EPS
0.15
0.12
-0.31
-0.62
-0.22
Diluted EPS
0.09
0.09
-0.31
-0.62
-0.22
Basic Average Shares
62,144
67,513
48,472
44,140
29,148
Diluted Average Shares
73,565
82,424
48,472
44,140
29,148
Total Operating Income as Reported
10,460
10,460
-13,014
-20,462
2,710
Total Expenses
55,034
55,034
60,652
58,812
60,188
Net Income from Continuing & Discontinued Operation
8,312
8,312
-14,927
-27,582
-6,523
Normalized Income
8,312
8,312
-14,927
-27,582
-6,523
Interest Income
1,286
1,286
1,146
401
438
Interest Expense
3,180
3,180
2,529
7,521
9,671
Net Interest Income
-1,894
-1,894
-1,383
-7,120
-9,233
EBIT
11,746
11,746
-11,868
-20,061
3,148
EBITDA
12,937
12,937
-10,782
-18,943
4,450
Reconciled Cost of Revenue
22,982
22,982
19,592
16,349
10,873
Reconciled Depreciation
1,191
1,191
1,086
1,118
1,302
Net Income from Continuing Operation Net Minority Interest
8,312
8,312
-14,927
-27,582
-6,523
Normalized EBITDA
12,937
12,937
-10,782
-18,943
4,450
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.